⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
STRO News
Sutro Biopharma, Inc.
Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
globenewswire.com
STRO
Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference
globenewswire.com
STRO
Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development
globenewswire.com
STRO
Form 8-K
sec.gov
STRO
Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
globenewswire.com
STRO
Form 8-K
sec.gov
STRO
Form 8-K
sec.gov
STRO
Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights
globenewswire.com
STRO
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
globenewswire.com
STRO
Atropos Health Publishes Methodology to Expand Precision Evidence Content
businesswire.com
STRO